title: Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.
abstract: Although Wnt-Frizzled (Fzd) signaling is critical in the pathophysiology of carcinomas, its role in human breast cancer has been difficult to establish. We show here that the adaptor protein Na(+)/H(+) exchange regulatory factor1 (NHERF1), a protein abundantly expressed in normal mammary epithelium, regulates Wnt signaling, maintaining low levels of β-catenin activation. NHERF1's effects are mediated by direct interactions between one of its PSD-95/drosophila discs large/ZO-1 (PDZ) domains and the C-terminus of a subset of Fzd receptors. Loss of NHERF1 in breast cancer cell lines enhances canonical Wnt signaling and Wnt-dependent cell proliferation. Furthermore, the mammary glands of NHERF1-knockout mice exhibit increased mammary duct density accompanied by increased proliferation and β-catenin activity. Finally, we demonstrate a negative correlation between NHERF1 expression and nuclear β-catenin in human breast carcinomas. Taken together, these results provide a novel insight into the regulation of Wnt signaling in normal and neoplastic breast tissues, and identify NHERF1 as an important regulator of the pathogenesis of breast tumors.
authors.affiliation: Laboratory for GPCR Biology, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Wheeler
authors.forename: S R
authors.initials: SR
authors.lastname: Barrick
authors.forename: M J
authors.initials: MJ
authors.lastname: Grubisha
authors.forename: A M
authors.initials: AM
authors.lastname: Brufsky
authors.forename: P A
authors.initials: PA
authors.lastname: Friedman
authors.forename: G
authors.initials: G
authors.lastname: Romero
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D049109:Cell Proliferation; D006224:Cricetinae; D003412:Cricetulus; D005260:Female; D051157:Frizzled Receptors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D017923:Sodium-Hydrogen Exchangers / Q000235:genetics / Q000378:metabolism*; D051176:beta Catenin / Q000235:genetics / Q000378:metabolism*
chemical_list: D051157:Frizzled Receptors; D010750:Phosphoproteins; D017923:Sodium-Hydrogen Exchangers; D051176:beta Catenin; C093376:sodium-hydrogen exchanger regulatory factor
references.citation: Oncogene. 2007 Aug 9;26(36):5290-9
references.pmid: 17325659
references.citation: JAMA. 2009 Aug 19;302(7):774-80
references.pmid: 19690310
references.citation: J Biol Chem. 2007 Aug 24;282(34):25076-87
references.pmid: 17599914
references.citation: J Biol Chem. 2007 Dec 14;282(50):36214-22
references.pmid: 17884816
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4262-6
references.pmid: 10759547
references.citation: Breast Cancer Res. 2006;8(4):212
references.pmid: 16887003
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3799-804
references.pmid: 16501043
references.citation: Int J Cancer. 2002 Mar 20;98(3):415-8
references.pmid: 11920593
references.citation: Oncogene. 2004 Aug 12;23(36):6023-30
references.pmid: 15195140
references.citation: Histopathology. 2007 Jul;51(1):40-53
references.pmid: 17593079
references.citation: Biophys J. 2006 Aug 1;91(3):1046-58
references.pmid: 16714353
references.citation: Nat Cell Biol. 2001 Sep;3(9):793-801
references.pmid: 11533658
references.citation: J Mol Biol. 2001 May 18;308(5):963-73
references.pmid: 11352585
references.citation: Adv Enzyme Regul. 2009;49(1):98-106
references.pmid: 19534027
references.citation: Breast Cancer Res. 2008;10(1):R5
references.pmid: 18190691
references.citation: Histopathology. 2009 Nov;55(5):600-8
references.pmid: 19912366
references.citation: Mol Endocrinol. 2009 Dec;23(12):2048-59
references.pmid: 19837945
references.citation: Breast Cancer Res. 2006;8(6):R63
references.pmid: 17078868
references.citation: Exp Cell Res. 2002 May 1;275(2):155-70
references.pmid: 11969287
references.citation: Int J Cancer. 1996 Apr 22;69(2):92-9
references.pmid: 8608989
references.citation: Dev Cell. 2007 Jan;12(1):129-41
references.pmid: 17199046
references.citation: Annu Rev Physiol. 2006;68:491-505
references.pmid: 16460281
references.citation: Cancer Res. 2006 May 15;66(10):5487-94
references.pmid: 16707478
references.citation: Am J Pathol. 2001 Jan;158(1):57-62
references.pmid: 11141479
references.citation: Oncogene. 2004 Nov 11;23(53):8681-7
references.pmid: 15467753
references.citation: Endocrinology. 1999 Jul;140(7):2976-82
references.pmid: 10385389
references.citation: Nature. 1999 Apr 1;398(6726):422-6
references.pmid: 10201372
references.citation: Mol Biol Cell. 2007 May;18(5):1768-80
references.pmid: 17332506
references.citation: Science. 1997 Jan 3;275(5296):73-7
references.pmid: 8974395
references.citation: Science. 2003 Sep 5;301(5638):1391-4
references.pmid: 12958364
references.citation: Oncogene. 2002 Jun 13;21(26):4080-8
references.pmid: 12037664
references.citation: Mol Biol Cell. 2008 Apr;19(4):1594-604
references.pmid: 18256285